Ingrid Louw

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)

Jeffrey Kaine, Geoffrey Gladstein, Ingrid Strusberg et al. · Annals of the Rheumatic Diseases · 2011 · 73 citations · Full text

Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis

Hermine I. Brunner, Nikolay Tzaribachev, Gabriel Vega‐Cornejo et al. · Arthritis & Rheumatology · 2018 · 67 citations · Full text

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

Bernard Combe, Bhaskar Dasgupta, Ingrid Louw et al. · Annals of the Rheumatic Diseases · 2013 · 31 citations · Full text

Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis

Nicolino Ruperto, Hermine I. Brunner, César Pacheco‐Tena et al. · Lara D. Veeken · 2021 · 30 citations · Full text